health
The growing development of complex biologics and advanced therapies is strengthening demand for testing services, according to a report from MarketsandMarkets.
Asia Pacific is expected to register the highest compound annual growth rate. The healthcare analytical testing services market is expected to reach $12b by 2031, driven by rising demand across pharmaceuticals, biopharmaceuticals, medical devices, and food, according to a MarketsandMarkets report. Key services include raw material and finished-product testing, analytical method development and validation, bioanalytical testing, extractables and leachables, trace metals, and residual solvent test
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy
Businesswire
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
Businesswire
QT Imaging to be Honored at Premier’s Annual Supplier Innovation Celebration
Businesswire
China takes decisive action to advance global development
Pr Newswire Apac
Project RED Expands Oregon's Overdose Prevention Efforts with Support from Boulder Care and Pearl Jam’s Vitalogy Foundation
Businesswire